How should we use convalescent plasma therapies for the management of COVID-19?
Blood. 2021 Mar 25;137(12):1573-1581. doi: 10.1182/blood.2020008903.
Blood. 2021.
PMID: 33202419
Free PMC article.
Review.
Convalescent plasma (CP) from blood donors with antibodies to severe acute respiratory syndrome coronavirus 2 may benefit patients with COVID-19 by providing immediate passive immunity via transfusion or by being used to manufacture hyperimmune …
Convalescent plasma (CP) from blood donors with antibodies to severe acute respiratory syndrome coronavirus 2 may benef …